Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If approved, they’ll be over $5.00 shortly after approval.
And they’ll for sure be on the Nasdaq soon after FDA approval, even if there’s a strong pullback from a $5.00 high.
There will be another leg up afterwards after some churn from LONGS.
I would say they’ll be on the Nasdaq by the end of this year, if they get FDA approved.
Official IDE submission and hype alone will take this far past $0.35.
It will hit $1.00 in the time period between submission to FDA and getting official approval/denial from the FDA.
This is a further cycle (IDE - human trials) than the BBD route was.
Even if BDD would have been approved, Korenko had already stated that IDE submission wouldn’t have been approved until Q2, or late Q2 anyways.
Once we actually get to May/June here, the price here will get “Real” just in the hype of human trials being around the corner.
It will be hyped all over the OTC, and on Twitter during that time.
Therefore, $1.00 (or at least $0.999), just before FDA approval/denial news.
If approved, that $1.00 per share will immediacy quadruple at least (probably straight to $5.00), before a sharp pullback.
Could even run to $8.00 - $10.00 quickly on approval news, before the pullback.
Tons of hype would be out there about how this just became the best cancer stock, etc.
I bought some more shares around $0.095 earlier today.
Even though my cost avg. is just below $0.04 here.
I’m fine with my decision today. This will skyrocket on IDE hype alone in latter Q2, whether it gets FDA approved or not.
It makes no sense for anyone to sell at these prices.
IDE submission and hype of that will drive this price up like crazy.
The O/S is currently at 296 million
What is it expected to get to, after this offering?
346 million?
What did they set the price at?
Over 2.1 million shares here still.
Still haven’t sold a single share here.
Who else here is in the ‘Million’ club for # of shares?
We know Champana has/had like 20 million shares or more.
I’m still a PASOholic.
You can’t have any of my “shurrs” ....
https://voca.ro/1hh1lzrBwPbI
He should of held.
We’re hitting $0.10+ here really soon.
Good catch ....
We should also get the China stock message boards to hype up IBGR.
I agree, and think share price here will be at least $2.00+
By the end of the year.
Even if it only spikes up for a few days and then pulls back to $1.50 by Dec. 31.
I still feel we’ll see $2.00+ at some point this year.
Yep, CLX deal is off ....
And PASO is on to a better business endeavor now with their partnership with Hestia and US Stem Cell.
Speaking of Champana
I wonder if he's still a shareholder here.
He didn't seem too thrilled with the way things were handled a couple of months ago.
And did he ever get on the board, or even a marketing position with RDGL?
The Dr. should include him in a high capacity.
Who knows, maybe I’m actually related to Bruce.
In a distant way.
Hey, you never know ....
https://voca.ro/17vUqNHfXsEE
We are so close to hitting the launch pad ....
https://voca.ro/1cJquE40KIdm
LaRoofus says we’re getting closer
https://voca.ro/1jyfysPJlVco
Thanks for that. There's more happening behind the scenes with PASO/HSTA than Pink.
How's the source for the 1B float claim coming?
AND JUST AS I "PREDICTED", PINK TODAY!
The rest of the catalysts will be falling into place all in due time. The stock is near the 52 week low. In my opinion, it won't be anywhere near .01XX for long. I've got "more than a feeling" we're about to see the tide about to rise with news right around the corner. But don't take my word for it... although I did happen to stay in a Holiday Inn Express last night.
It's been a rough ride, but patience will very likely pay here soon. Very soon.
Yep, PASO is now Pink “current” on OTC Markets
Can’t wait for the upcoming run up ....
https://voca.ro/13t714UrUdjD
UA has a $9 billion market cap.
Imagine DRYW with a $20 billion market cap a few years from now.
That is $121.21 per share (at 165 million outstanding shares).
if true, 4 out of 5 doctors don’t recommend PASO
Which is fine.
Therefore, the 1 out of 5 doctors that actually know anything about mental health, they know how big this will be.
There have been large buyers who have been “loading” shares here over the past couple of weeks.
That’s really all we needed to see in telling us what’s going to happen here.
Remember Boob, it’s not about the number of Boobs in your hands.
It’s the size of the Boob that truly counts.
They had to walk it down to ....
Show a purchase that happened at $0.0911
911’s have been revealed to us recently.
This should run soon.
We will get news here.
Sounds good, but ....
Let me know how your new music video is going ..........
It will go much higher than $0.026
Here is a brief background of rTMS - the technology that will be used in the PASO/HSTA Health clinics.
Transcranial magnetic stimulation and rTMS have been used to treat many psychological and medical disorders such as major depressive disorder, Parkinson's disease , PTSD, Alzheimer's disease, autism spectrum disorder (ASD), schizophrenia, pain management and others . Recently, Jin and Phillips, in US Patent Publication 2009/0082690, have disclosed a treatment protocol using rTMS where the output of the magnetic field is adjusted based on a patient's EEG intrinsic frequencies in an attempt to alter the patient's intrinsic EEG frequencies. U.S. Pat. No. 9, 308, 385 uses a different approach to administer rTMS by using a frequency based on a biological metric or an harmonic of a biological metric.
Physiological conditions and medical conditions that can be improved by modulating the brain activity according to the present invention are any conditions where abnormal brain activity contributes to a specific condition. Improvements are seen when the amplitude of the desired or targeted brain wave bands acquire an increase in amplitude or relative power density. Conditions that are treated include but are not limited to autism spectrum disorder (ASD), Alzheimer's Disease (AD), Post Traumatic Stress Disorder (PTSD), Traumatic Brain Injury (TBI), memory impairment, depression, pain, addiction, Obsessie Compulsive disor ders (OCD), anxiety, Parkinson's disease, hypertension, libido dysfunction, motor function abnormalities, small height in young children, stress, obesity, sleep disorders, eating disorders, concentration/focus abnormalities, speech abnormalities, intelligence deficits, cognition abnormalities, Attention Deficit Hyperactivity Disorders (ADHD), schizo phrenia, coma, bipolar disorders, tinnitus, fibromyalgia, chronic Lyme disease, Rheumatoid arthritis and other auto immune disease.
No amount of likelihood will stop PASO/HSTA from pursuing FDA approval for their variance of rTMS (CLASS I). However, should their variance prove to not qualify for approval, it will almost certainly be "CLEARED" by the FDA (CLASS II) IMO. There is not a lack of evidence supporting TMS being CLASS II cleared.
If everyone we wanted to do something revolutionary or for "one of the first times" didn't attempt because there was a dearth in studies, we'd never move forward. This fact alone is exciting while holding a position in PASO.
PASO has already addressed the insurance aspect. They are working it.
I’m referring to FDA approval for rTMS.
As I previously mentioned, there is other similar technology that has already been FDA approved (rTMS variance).
The fact that the similar technology was FDA approved doesn't necessarily guarantee FDA approval for the HSTA/PASO rTMS method that will be used, but it does help the cause tremendously, and makes things very straightforward for the FDA.
Here is some background information on what the FDA does and where the HSTA/PASO rTMS patented technology comes into play:
The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.
Of particular interest in practicing the present invention, a patient is subjected to repetitive transcranial magnetic stimulation (rTMS) with variable pulse intervals for a time sufficient to modulate a brain activity in the patient where an improvement in a physiological condition or a clinical condition is achieved. The patient is subjected to an EEG to create an EEG data set. The EEG data set is analyzed with a wavelet transform. The extracted signal by wavelet transform analysis is then used to program the variable pulse intervals (frequencies and amplitudes) into the rTMS apparatus. The wavelet transform algorithm extracts a unique EEG signal and variable pulse interval profile that results in the desired improvements in the physiological or medical condition that is being treated.
Should be showing as current by Friday
When this gets to $3.00, that would be early retirement for me
I have 4.2+ million shares.
$3.00 gets me well above $12 million.
Even after paying taxes, I’m comfortable with a net amount of $8 million range.
Most of my shares are long-term hold now for long-term capital gains.
But I will probably still save at least a million shares for $10 share price down the road.
Becoming Pink Current with OTCM was only part of my post. Being current all by itself wouldn't be worth much, but that's why I included the other information. So, yes, I do think it's worth starting a position here... especially with PTSD , anxiety, and depression numbers currently being recorded at twice the average rate in the U.S.
If PASO can successfully open and operate these Health clinics with HSTA, let's just say there won't be a shortage of clients. Additionally, the specific type of repetitive transcranial magnetic stimulation (rTMS) technology they are going to be leveraging is technology that will be exclusive to PASO/HSTA clinics...... Until they attempt to license this technology in the U.S. and around the world. I suspect they will need FAR less time to show "proof-of-concept" because similar technology already exists and has been FDA approved.
This means we have SEVERAL MAJOR CATALYSTS pending:
1) OTC Pink Current
2) Dividend Value
3) PASO/HSTA MOU
4) File for FDA approval
5) First Clinic opening
6) Filings with real revenue
7) Additional clinics opening
8) FDA approval
9) Partnership agreements
10) Licencing agreements
If done correctly, this stock should be dollars in the next 12-18 months.... That's also taking into consideration the recent share structure changes. 700M float is more than the 250M it once was, but it's also not 1.5B+ like many other OTC stocks are.
This stock is ready to run, and I just described a number of catalysts that will make that happen several times over the next 12 months... The first one happening THIS WEEK.
That’s not the only thing you see here Boob
You now have an official theme song that plays in the background, every time you step in to ‘The Ring’ ..........
Reminder: Attorney Letter from earlier today.
https://backend.otcmarkets.com/otcapi/company/financial-report/271904/content
From today (Feb. 23):
https://www.otcmarkets.com/stock/PASO/disclosure
Great news coming soon.
Just two words .... GET READY
#GetReady
Honest response... probably should be a little more tied in what's going on here as a mod, don't ya think?
To answer your question, you can start here...
https://www.globenewswire.com/news-release/2021/02/02/2168581/0/en/Update-Patient-Access-Solutions-Hestia-Insight-and-US-Stem-Cell-to-Form-Business-Consortium.html
Then here to see that PASO has filed ALL required documents with OTCM for current status (I suspect we'll be current by Friday)
https://www.otcmarkets.com/stock/PASO/disclosure
Then here...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161774495
Enjoy
-Roofus
(The Roofus On Fire)
I’m just gonna leave this right here.
Yep, 5 free shares for each post.
If we ran up 4000% before, we can certainly do it again.
The next leg up here is going to be epic.
Song of the Day
Actually, crackhead LaRoofus says ‘Buy Now’
Perfect buying level right now for what’s to come ....
https://voca.ro/15dx6WiVrceE
And this was as low as $0.005 during those delays at one point.
Then we eventually ran all the way up to $0.20.
That’s a 40 bagger, basically 4,000% increase.
And another 4,000% increase from current price now will take us to $4.80.
Right about where Choi expects this to get to in the short-term.
It looks like some sellers don’t believe that Choi actually talked to Matt yesterday.
I personally believe Choi.
His credibility on here is literally off the charts, with his terrific DD.
The day we go current, we should easily see a new 52-week high that day.